RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations

British Journal of Dermatology

Volumn 158, Issue 5, 2008, Pages 1035-1040

  Hershkovitz, D ^a,b   Bercovich, D ^c   Sprecher, E ^a,b   Lapidot, M ^d  

^a Laboratory of Molecular Dermatology   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

Genetics; Mutation; Port wine stain; RASA1

Indexed keywords

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; GENE; GENE LOCUS; GENE MUTATION; HUMAN; INFANT; MALE; MARKER GENE; MUTATIONAL ANALYSIS; NEVUS FLAMMEUS; PEDIGREE; PRESCHOOL CHILD; PRIORITY JOURNAL; RASA1 GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; HUMANS; INFANT; MALE; MICROSATELLITE REPEATS; MUTATION; P120 GTPASE ACTIVATING PROTEIN; PEDIGREE; PORT-WINE STAIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 42049117619     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08493.x     Document Type: Article

References (14)

1. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976 58 : 218 22.
2. Garzon MC, Huang JT, Enjolras O et al. Vascular malformations: Part I. J Am Acad Dermatol 2007 56 : 353 70 quiz 71-4.
3. Brouillard P, Vikkula M. Vascular malformations: localized defects in vascular morphogenesis. Clin Genet 2003 63 : 340 51.
4. Eerola I, Boon LM, Mulliken JB et al. Capillary malformation- arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003 73 : 1240 9.
5. Trahey M, Wong G, Halenbeck R et al. Molecular cloning of two types of GAP complementary DNA from human placenta. Science 1988 242 : 1697 700.
6. Henkemeyer M, Rossi DJ, Holmyard DP et al. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 1995 377 : 695 701.
7. Kulkarni SV, Gish G, van der Geer P et al. Role of p120 Ras-GAP in directed cell movement. J Cell Biol 2000 149 : 457 70.
8. Bercovich D, Beaudet AL. Denaturing high-performance liquid chromatography for the detection of mutations and polymorphisms in UBE3A. Genet Test 2003 7 : 189 94.
9. Cohen MM Jr. Vascular update: morphogenesis, tumors, malformations, and molecular dimensions. Am J Med Genet A 2006 140 : 2013 38.
10. Plauchu H, de Chadarevian JP, Bideau A et al. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989 32 : 291 7.
11. Johnson DW, Berg JN, Baldwin MA et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996 13 : 189 95.
12. McAllister KA, Grogg KM, Johnson DW et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994 8 : 345 51.
13. Vikkula M, Boon LM, Carraway KL 3rd. et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996 87 : 1181 90.
14. Brouillard P, Boon LM, Mulliken JB et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ('glomangiomas'). Am J Hum Genet 2002 70 : 866 74.